Therapies to treat IBD are associated with an increased risk of infection, as anti-TNF inhibitors are associated with an increase in pneumonia, but vaccination against pneumococcus is associated with a reduced risk of pneumonia (65). Here, TNF is linked to susceptibility to pneumonia measurement.